Jim Cramer highlights NUVB Fast Track and favors CRWV, BOX
On CNBC’s “Mad Money Lightning Round,” Jim Cramer called Nuvation Bio a “pure spec” after its FDA Fast Track Designation. He favored CoreWeave over “neoclouds” and praised Box after its Q2 results.